PatientsVille.com Logo

PatientsVille

Serenace Side Effects

Common Serenace Side Effects


The most commonly reported Serenace side effects (click to view or check a box to report):

Schizophrenia (3)
Psychiatric Symptom (3)
Motor Dysfunction (3)
Activities Of Daily Living Impaired (3)
Asocial Behaviour (3)
Hallucination (3)
Blood Pressure Increased (3)
Blood Creatine Phosphokinase Increased (3)
Anxiety (3)
Disturbance In Attention (3)
Neuroleptic Malignant Syndrome (2)
Bladder Catheterisation (2)
Asthenia (2)
Depressed Level Of Consciousness (2)
Death (2)
Body Temperature Increased (2)
Feeling Hot (2)
Heart Rate Increased (2)
Blood Creatinine Increased (1)
Blood Urea Increased (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Serenace Side Effects Reported to FDA

The following Serenace reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Serenace on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

This is a report of a 75-year-old male patient (weight: NA) from ZA, suffering from the following symptoms/conditions: psychotic disorder, who was treated with Serenace (dosage: 5 Mg, 2x/day (bd), start time: Aug 01, 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Serenace treatment in male patients, resulting in death side effect. The patient was hospitalized.

    Pneumonitis, Delirium
    This report suggests a potential Serenace Pneumonitis, Delirium side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: delirium and used Serenace (dosage: NA) starting Feb 14, 2012. Soon after starting Serenace the patient began experiencing various side effects, including:
    • Pneumonitis
    • Delirium
    Drugs used concurrently:
    • Haloperidol
    • Crizotinib
    • Tamsulosin Hydrochloride
    • Diovan
    • Loxoprofen
    • Protecadin
    • S. Adchnon
    • Transamin
    The patient was hospitalized. Although Serenace demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pneumonitis, may still occur.


    This problem was reported by a physician from JAPAN. A 83-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: schizophrenia,dementia,osteoporosis. On Jan 25, 2010 this consumer started treatment with Serenace (dosage: 1 Mg, Qd). The following drugs were being taken at the same time:
    • Aricept (5 Mg, Qd)
    • Forteo (20 Ug, Qd)
    • Bonalon (5 Mg, Qd)
    When commencing Serenace, the patient experienced the following unwanted symptoms/side effects:
      Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as death, may become evident only after a product is in use by the general population.

      Erythema Multiforme, Platelet Count Decreased, Hepatic Function Abnormal, C-reactive Protein Increased, Pyrexia
      This is a report of a 73-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Serenace (dosage: NA) starting Mar 23, 2010. Concurrently used drugs:
      • Sunitinib Malate (37.5 Mg, Daily)
      • Norvasc
      Soon after that, the consumer experienced the following side effects:
      • Erythema Multiforme
      • Platelet Count Decreased
      • Hepatic Function Abnormal
      • C-reactive Protein Increased
      • Pyrexia
      The patient was hospitalized. This opens a possibility that Serenace treatment could cause the above reactions, including erythema multiforme, and some female subjects may be more susceptible.


      Neurological Symptom
      A 50-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: bipolar i disorder started Serenace treatment (dosage: NA) on NS. Soon after starting Serenace treatment, the subject experienced various side effects, including:
      • Neurological Symptom
      Concurrently used drugs:
      • Risperdal
      • Fluvoxamine Maleate
      The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Serenace.

      Chest Pain, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Blood Urea Increased, Abdominal Pain, Occult Blood, Protein Urine Present, Blood Creatinine Increased, Blood Bilirubin Increased
      A 68-year-old female patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Serenace(dosage: 1.5 Mg, 1x/day). The treatment was initiated on Nov 02, 2010. After that a consumer reported the following side effect(s):
      • Chest Pain
      • Aspartate Aminotransferase Increased
      • Alanine Aminotransferase Increased
      • Blood Urea Increased
      • Abdominal Pain
      • Occult Blood
      • Protein Urine Present
      • Blood Creatinine Increased
      • Blood Bilirubin Increased
      Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Serenace efficacy:
      • Methylnaltrexone Bromide (0.3 Mg/kg, Single)
      • Takepron (15 Mg, 1x/day)
      • Novamin (5 Mg, As Needed)
      • Fentanyl Citrate (4 Mg, 1x/day)
      • Morphine Hydrochloride (10 Mg, As Needed)
      • Fentanyl Citrate (1 Mg, 1x/day)
      • Aldactone (25 Mg, 1x/day)
      • Magnesium Oxide (750 Mg, 1x/day)
      The patient was hospitalized and became disabled.

      Dystonia, Overdose, Product Name Confusion
      In this report, Serenace was administered for the following condition: NA.A 5-year-old male consumer from INDIA (weight: NA) started Serenace treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
      • Dystonia
      • Overdose
      • Product Name Confusion
      A possible interaction with other drugs could have contributed to this reaction:
      • Serronak
      Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Serenace treatment could be related to the listed above side effect(s).

      Activities Of Daily Living Impaired, Anxiety, Asocial Behaviour, Disturbance In Attention, Hallucination, Motor Dysfunction, Psychiatric Symptom, Schizophrenia
      This is a report of the following Serenace side effect(s):
      • Activities Of Daily Living Impaired
      • Anxiety
      • Asocial Behaviour
      • Disturbance In Attention
      • Hallucination
      • Motor Dysfunction
      • Psychiatric Symptom
      • Schizophrenia
      A 29-year-old female patient from AUSTRALIA (weight: NA) presented with the following condition: NA and received a treatment with Serenace (dosage: NA) starting: Jan 01, 2001.The following concurrently used drugs could have generated interactions:
      • Tegretol (100 Mg, Tid)
      • Tegretol (100 Mg, Bid)
      • Epilim (100 Mg, Qd, At Night)
      • Epilim (150 Mg, Qd, At Night)
      • Mellaril (Unk, Unk)
      • Mellaril (100mg(morning And Night) + 50mg(midday))
      This report suggests that a Serenace treatment could be associated with the listed above side effect(s).

      Activities Of Daily Living Impaired, Anxiety, Asocial Behaviour, Disturbance In Attention, Hallucination, Motor Dysfunction, Psychiatric Symptom, Schizophrenia
      This Serenace report was submitted by a 29-year-old female consumer from AUSTRALIA (weight: NA). The patient was diagnosed with: NA and Serenace was administered (dosage: NA) starting: Jan 01, 1979. The consumer developed a set of symptoms:
      • Activities Of Daily Living Impaired
      • Anxiety
      • Asocial Behaviour
      • Disturbance In Attention
      • Hallucination
      • Motor Dysfunction
      • Psychiatric Symptom
      • Schizophrenia
      Other drugs used simultaneously:
      • Tegretol (100 Mg, Tid)
      • Tegretol (100 Mg, Bid)
      • Epilim (100 Mg, Qd, At Night)
      • Epilim (150 Mg, Qd, At Night)
      • Mellaril (Unk, Unk)
      • Mellaril (100mg(morning And Night) + 50mg(midday))
      Those unexpected symptoms could be linked to a Serenace treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

      Activities Of Daily Living Impaired, Anxiety, Asocial Behaviour, Disturbance In Attention, Hallucination, Motor Dysfunction, Psychiatric Symptom, Schizophrenia
      This is a report of a possible correlation between Serenace use and the following symptoms/side effect(s):
      • Activities Of Daily Living Impaired
      • Anxiety
      • Asocial Behaviour
      • Disturbance In Attention
      • Hallucination
      • Motor Dysfunction
      • Psychiatric Symptom
      • Schizophrenia
      which could contribute to an assessment of Serenace risk profile.A 29-year-old female consumer from AUSTRALIA (weight: NA) was suffering from NA and was treated with Serenace (dosage: NA) starting Jan 01, 1979.Other concurrent medications:
      • Tegretol (100 Mg, Tid)
      • Tegretol (100 Mg, Bid)
      • Epilim (100 Mg, Qd, At Night)
      • Epilim (150 Mg, Qd, At Night)
      • Mellaril (Unk, Unk)
      • Mellaril (100mg(morning And Night) + 50mg(midday))


      Neuroleptic Malignant Syndrome
      A 67-year-old male patient from JAPAN (weight: NA) presented with the following symptoms: delusion,hallucination and after a treatment with Serenace (dosage: 2.25 Mg/d) experienced the following side effect(s):
      • Neuroleptic Malignant Syndrome
      The treatment was started on May 30, 2003. Serenace was used in combination with the following drugs: NA.This report could alert potential Serenace consumers.

      Neuroleptic Malignant Syndrome
      In this report, a 67-year-old male patient from (weight: NA) was affected by a possible Serenace side effect.The patient was diagnosed with delusion,hallucination. After a treatment with Serenace (dosage: 2.25 Mg/d, start date: May 30, 2003), the patient experienced the following side effect(s):
      • Neuroleptic Malignant Syndrome
      The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Serenace treatment.

      Asthenia, Bladder Catheterisation, Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Body Temperature Increased, Depressed Level Of Consciousness, Feeling Hot, Heart Rate Increased
      This is a report of a 69-year-old female patient from (weight: NA), who used Serenace (dosage: 3 Mg/day) for a treatment of schizophrenia. After starting a treatment on Sep 30, 2004, the patient experienced the following side effect(s):
      • Asthenia
      • Bladder Catheterisation
      • Blood Creatine Phosphokinase Increased
      • Blood Pressure Increased
      • Body Temperature Increased
      • Depressed Level Of Consciousness
      • Feeling Hot
      • Heart Rate Increased
      The following drugs could possibly have interacted with the Serenace treatment
      • Mellaril (75 Mg/day)
      • Lamisil (125 Mg, Qd)
      The patient was hospitalized.Taken together, these observations suggest that a Serenace treatment could be related to side effect(s), such as Asthenia, Bladder Catheterisation, Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Body Temperature Increased, Depressed Level Of Consciousness, Feeling Hot, Heart Rate Increased.

      Asthenia, Bladder Catheterisation, Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Body Temperature Increased, Depressed Level Of Consciousness, Feeling Hot, Heart Rate Increased
      This asthenia side effect was reported by a physician from . A 69-year-old female patient (weight:NA) experienced the following symptoms/conditions: schizophrenia. The patient was prescribed Serenace (dosage: 3 Mg/day), which was started on Sep 30, 2004. Concurrently used drugs:
      • Mellaril (75 Mg/day)
      • Lamisil (125 Mg, Qd)
      When starting to take Serenace the consumer reported the following symptoms:
      • Asthenia
      • Bladder Catheterisation
      • Blood Creatine Phosphokinase Increased
      • Blood Pressure Increased
      • Body Temperature Increased
      • Depressed Level Of Consciousness
      • Feeling Hot
      • Heart Rate Increased
      The patient was hospitalized. These side effects may potentially be related to Serenace.

      Blood Pressure Increased, Caesarean Section, Excitability, Foetal Distress Syndrome, Foetal Heart Rate Abnormal, Insomnia, Spinal Anaesthesia
      This is a Serenace side effect report of a 38-year-old female patient (weight:NA) from , suffering from the following symptoms/conditions: NA, who was treated with Serenace (dosage:NA, start time: Aug 01, 2003), combined with:
      • Akineton
      • Hydralazine Hcl
      • Magnesium
      , and developed a serious reaction and a blood pressure increased side effect. The patient presented with:
      • Blood Pressure Increased
      • Caesarean Section
      • Excitability
      • Foetal Distress Syndrome
      • Foetal Heart Rate Abnormal
      • Insomnia
      • Spinal Anaesthesia
      which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Serenace treatment in female patients suffering from NA, resulting in blood pressure increased.

      Blood Creatine Phosphokinase Increased, Malaise, Rhabdomyolysis
      This report suggests a potential Serenace blood creatine phosphokinase increased side effect(s) that can have serious consequences. A 60-year-old female patient from (weight:NA) was diagnosed with the following health condition(s): schizophrenia and used Serenace (dosage: 3 Mg/d) starting Dec 21, 2004. Soon after starting Serenace the patient began experiencing various side effects, including:
      • Blood Creatine Phosphokinase Increased
      • Malaise
      • Rhabdomyolysis
      Drugs used concurrently:
      • Melleril (30 Mg/d)
      • Lamisil (125 Mg, Qd)
      Although Serenace demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as blood creatine phosphokinase increased, may still occur.



      Keep Track of Side Effects

      Note Your Observations

      It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

      Why Your Notes are Important

      Your notes could be helpful in several ways:

    • You can use them to remind you of details that may alert your health care professional(s) to a problem
    • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

    • Log Form

      You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

      Medicine Name and Dosage:
      Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
      Scale: 1 = very mild to 10 = very bad

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


      Discuss Serenace Side Effects

      Did You Have a Serenace Side Effect?

      Yes, Severe
      Yes, Moderate
      Yes, Minor
      No

      How Effective is Serenace for You?

      Exceeded Expectations
      Effective
      Somewhat Effective
      Not Effective

      Serenace Safety Alerts, Active Ingredients, Usage Information

      More About Serenace

      Side Effects reported to FDA: 16

      Serenace safety alerts: No

      Reported deaths: 4

      Reported hospitalizations: 7

      Latest Serenace clinical trials